The efficacy and safety of the targeted drug combined with adriamycin liposome solution for HER-2-positive breast cancer
Objective: To study the efficacy and safety of the targeted drug trastuzumab combined with adriamycin liposome solution for HER-2-positive breast cancer. Methods: A total of 112 patients with breast cancer who received chemotherapy in Department of Cardiothoracic Breast Surgery, Guangdong TongJia...
Main Authors: | Zi-Ping Zhou, Jian-Hao Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Board of Journal of Hainan Medical University
2017-05-01
|
Series: | Journal of Hainan Medical University |
Subjects: | |
Online Access: | http://www.hnykdxxb.com/PDF/201709/30.pdf |
Similar Items
-
Adriamycin - efficacy and possible adverse effects
by: Pedrycz Agnieszka, et al.
Published: (2016-03-01) -
Investigation of The Effects of Pleurotus Eryngii Extract on Adriamycin-İnduced Cardiotoxicity in Sprague-Dawley Rats
by: Elif Erdem Güzel
Published: (2021-06-01) -
The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer
by: Chaokun Wang, et al.
Published: (2021-05-01) -
Reversal of Doxorubicin-induced Cardiotoxicity by Using Phytotherapy: A Review
by: Azar Hosseini, et al.
Published: (2017-12-01) -
Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
by: Franco YL, et al.
Published: (2018-09-01)